Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
Conditions
- Recurrent T Acute Lymphoblastic Leukemia
- Refractory T Acute Lymphoblastic Leukemia
- Refractory T Lymphoblastic Lymphoma
- T Lymphoblastic Lymphoma
Interventions
- DRUG: AKR1C3-activated Prodrug AST-3424
- PROCEDURE: Biopsy Procedure
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Computed Tomography
Sponsor
SWOG Cancer Research Network
Collaborators